Inactivation of the IL-6 gene prevents development of multicentric Castleman's disease in C/EBP beta-deficient mice
暂无分享,去创建一个
P. Musiani | I. Screpanti | D. Bellavia | V. Poli | L. Frati | A. Gulino | F. Aiello | M. Cappelletti | A. Modesti | M. Maroder
[1] R. Cortese,et al. Lymphoproliferative disorder and imbalanced T‐helper response in C/EBP beta‐deficient mice. , 1995, The EMBO journal.
[2] Nobuaki Yoshida,et al. Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages , 1995, Cell.
[3] A. Kuramoto,et al. Differentiation of early plasma cells on bone marrow stromal cells requires interleukin-6 for escaping from apoptosis. , 1995, Blood.
[4] A. Green,et al. Molecular analysis of chromosome 20q deletions associated with myeloproliferative disorders and myelodysplastic syndromes , 1994 .
[5] A. Green,et al. Deletion of chromosome 20q in myelodysplasia can occur in a multipotent precursor of both myeloid cells and B cells. , 1994, Blood.
[6] R. Zinkernagel,et al. Impaired immune and acute-phase responses in interleukin-6-deficient mice , 1994, Nature.
[7] B. Klein,et al. Brief report: alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibody. , 1994, The New England journal of medicine.
[8] G. Ciliberto,et al. Interleukin‐6 deficient mice are protected from bone loss caused by estrogen depletion. , 1994, The EMBO journal.
[9] B. Peterson,et al. Multicentric Castleman's disease. , 1993, Seminars in oncology.
[10] M. Stoffel,et al. Molecular genetics of myeloid leukemia: identification of the commonly deleted segment of chromosome 20. , 1993, Blood.
[11] R. Cortese,et al. IL-6DBP, a nuclear protein involved in interleukin-6 signal transduction, defines a new family of leucine zipper proteins related to C EBP , 1990, Cell.
[12] A. Nienhuis,et al. Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice. , 1990, The Journal of clinical investigation.
[13] S. Akira,et al. A nuclear factor for IL‐6 expression (NF‐IL6) is a member of a C/EBP family. , 1990, The EMBO journal.
[14] B. Klein,et al. Interleukin-6 is a potent myeloma-cell growth factor in patients with aggressive multiple myeloma. , 1989, Blood.
[15] S. Akira,et al. Biological and clinical aspects of interleukin 6. , 1990, Immunology today.
[16] T. Komori,et al. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. , 1989, Blood.